These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 289370)

  • 81. Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer.
    Kwai AH; Stomper PC; Kaplan WD
    J Nucl Med; 1988 Mar; 29(3):324-8. PubMed ID: 3346742
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bone scanning in patients with early breast carcinoma: should it be a routine staging procedure?
    Lee YT
    Cancer; 1981 Feb; 47(3):486-95. PubMed ID: 6261910
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of bone scan in breast cancer follow-up.
    Maffioli L; Zambetti M; Castellani MR; Bombardieri E
    Tumori; 1997; 83(2):547-9. PubMed ID: 9226017
    [No Abstract]   [Full Text] [Related]  

  • 84. Letter: Preoperative management of breast cancer.
    N Engl J Med; 1975 Mar; 292(11):593. PubMed ID: 1110680
    [No Abstract]   [Full Text] [Related]  

  • 85. The role of radionuclide studies in breast cancer.
    al-Nahhas AM; McCready VR
    Nucl Med Commun; 1993 Mar; 14(3):192-6. PubMed ID: 8455910
    [No Abstract]   [Full Text] [Related]  

  • 86. Prognosis in breast cancer: the relevance of clinical staging.
    Langlands AO; Kerr GR
    Clin Radiol; 1978 Nov; 29(6):599-606. PubMed ID: 737949
    [No Abstract]   [Full Text] [Related]  

  • 87. Prognostic factors and tumour markers in early breast cancer; a commentary.
    Bulbrook RD
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1693-7. PubMed ID: 6686554
    [No Abstract]   [Full Text] [Related]  

  • 88. [12．Uncertainty in Quantitative Bone Scintigraphy].
    Yamamoto Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2020; 76(6):620-625. PubMed ID: 32565521
    [No Abstract]   [Full Text] [Related]  

  • 89. Receptor imaging in breast carcinoma: future prospects.
    Van de Wiele C; Van Belle S; Sleghers G; Dierckx RA
    Eur J Nucl Med; 2001 Jun; 28(6):675-9. PubMed ID: 11440026
    [No Abstract]   [Full Text] [Related]  

  • 90. A Comparative Study of Bone Scan Findings and Serum Levels of Tumor Marker CA15-3 in Patients with Breast Carcinoma.
    Ghadge MS; Naik PP; Tiwari BP; Hegde RM; Matale TJ
    Indian J Clin Biochem; 2012 Jan; 27(1):97-9. PubMed ID: 23277720
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and Excerpts.
    Donohoe KJ; Cohen EJ; Giammarile F; Grady E; Greenspan BS; Henkin RE; Millstine J; Smith GT; Srinivas S; Kauffman J; Ahuja S
    J Nucl Med; 2017 Apr; 58(4):14N-17N. PubMed ID: 28373397
    [No Abstract]   [Full Text] [Related]  

  • 92. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
    Anger K; Möller T; Zeimantz E
    Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
    [TBL] [Abstract][Full Text] [Related]  

  • 93. 'For' or 'against' bone scintigraphy of patients with breast cancer.
    Derimanov SG
    Nucl Med Commun; 1987 Feb; 8(2):79-86. PubMed ID: 3587793
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Staging workup of breast carcinoma in the community hospital.
    Hayes J; Dunn E
    Conn Med; 1988 Jun; 52(6):335-8. PubMed ID: 3293904
    [No Abstract]   [Full Text] [Related]  

  • 95. An analysis of bone scintigraphy in early (operable) breast cancer.
    Kitchen PR; Andrews JT; Buckley JD; Russell IS; Lichtenstein M; McLean K; Forbes JF
    Aust N Z J Surg; 1979 Jun; 49(3):313-6. PubMed ID: 289370
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.